vs
CALAVO GROWERS INC（CVGW）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是CALAVO GROWERS INC的1.6倍（$197.9M vs $124.7M），REPLIGEN CORP净利率更高（6.7% vs 3.1%，领先3.7%），REPLIGEN CORP同比增速更快（13.6% vs -26.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $1.2M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -1.2%）
卡拉沃种植者公司是一家国际化农产消费品企业，核心业务涉及牛油果及其他鲜果、新鲜预制食品的包装与分销，产品面向全球各地的餐饮门店、零售卖场以及个人客户供应，是生鲜果蔬领域颇具规模的供应商。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CVGW vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$124.7M
营收增速更快
RGEN
高出40.3%
-26.6%
净利率更高
RGEN
高出3.7%
3.1%
自由现金流更多
RGEN
多$16.3M
$1.2M
两年增速更快
RGEN
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.7M | $197.9M |
| 净利润 | $3.8M | $13.3M |
| 毛利率 | 9.3% | 52.5% |
| 营业利润率 | -1.4% | 9.0% |
| 净利率 | 3.1% | 6.7% |
| 营收同比 | -26.6% | 13.6% |
| 净利润同比 | 2846.0% | 143.9% |
| 每股收益（稀释后） | $0.22 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVGWRGEN
| Q4 25 | $124.7M | $197.9M | ||
| Q3 25 | $178.8M | $188.8M | ||
| Q2 25 | $190.5M | $182.4M | ||
| Q1 25 | $154.4M | $169.2M | ||
| Q4 24 | $170.0M | $174.1M | ||
| Q3 24 | $179.6M | $154.9M | ||
| Q2 24 | $184.4M | $154.1M | ||
| Q1 24 | $127.6M | $151.3M |
净利润CVGWRGEN
| Q4 25 | $3.8M | $13.3M | ||
| Q3 25 | $4.7M | $14.9M | ||
| Q2 25 | $6.8M | $14.9M | ||
| Q1 25 | $4.4M | $5.8M | ||
| Q4 24 | $-139.0K | $-30.3M | ||
| Q3 24 | $-732.0K | $-654.0K | ||
| Q2 24 | $6.1M | $3.3M | ||
| Q1 24 | $-6.3M | $2.1M |
毛利率CVGWRGEN
| Q4 25 | 9.3% | 52.5% | ||
| Q3 25 | 10.2% | 53.2% | ||
| Q2 25 | 9.5% | 50.0% | ||
| Q1 25 | 10.2% | 53.6% | ||
| Q4 24 | 9.7% | 26.1% | ||
| Q3 24 | 11.2% | 50.0% | ||
| Q2 24 | 11.1% | 49.8% | ||
| Q1 24 | 8.4% | 49.5% |
营业利润率CVGWRGEN
| Q4 25 | -1.4% | 9.0% | ||
| Q3 25 | 4.8% | 8.9% | ||
| Q2 25 | 4.0% | 7.6% | ||
| Q1 25 | 3.3% | 3.9% | ||
| Q4 24 | 1.8% | -17.7% | ||
| Q3 24 | 5.2% | -5.1% | ||
| Q2 24 | 4.0% | 1.0% | ||
| Q1 24 | -2.4% | 1.3% |
净利率CVGWRGEN
| Q4 25 | 3.1% | 6.7% | ||
| Q3 25 | 2.6% | 7.9% | ||
| Q2 25 | 3.6% | 8.2% | ||
| Q1 25 | 2.9% | 3.4% | ||
| Q4 24 | -0.1% | -17.4% | ||
| Q3 24 | -0.4% | -0.4% | ||
| Q2 24 | 3.3% | 2.2% | ||
| Q1 24 | -4.9% | 1.4% |
每股收益（稀释后）CVGWRGEN
| Q4 25 | $0.22 | $0.24 | ||
| Q3 25 | $0.26 | $0.26 | ||
| Q2 25 | $0.38 | $0.26 | ||
| Q1 25 | $0.25 | $0.10 | ||
| Q4 24 | $-0.01 | $-0.55 | ||
| Q3 24 | $-0.04 | $-0.01 | ||
| Q2 24 | $0.34 | $0.06 | ||
| Q1 24 | $-0.35 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $61.2M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $206.9M | $2.1B |
| 总资产 | $292.2M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CVGWRGEN
| Q4 25 | $61.2M | $767.6M | ||
| Q3 25 | $63.8M | $748.7M | ||
| Q2 25 | $60.4M | $708.9M | ||
| Q1 25 | $48.5M | $697.2M | ||
| Q4 24 | $57.0M | $757.4M | ||
| Q3 24 | $1.1M | $784.0M | ||
| Q2 24 | $4.3M | $809.1M | ||
| Q1 24 | $5.7M | $780.6M |
总债务CVGWRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CVGWRGEN
| Q4 25 | $206.9M | $2.1B | ||
| Q3 25 | $206.4M | $2.1B | ||
| Q2 25 | $206.6M | $2.1B | ||
| Q1 25 | $202.9M | $2.0B | ||
| Q4 24 | $200.3M | $2.0B | ||
| Q3 24 | $205.2M | $2.0B | ||
| Q2 24 | $207.3M | $2.0B | ||
| Q1 24 | $202.5M | $2.0B |
总资产CVGWRGEN
| Q4 25 | $292.2M | $2.9B | ||
| Q3 25 | $301.2M | $2.9B | ||
| Q2 25 | $321.5M | $2.9B | ||
| Q1 25 | $298.9M | $2.9B | ||
| Q4 24 | $301.1M | $2.8B | ||
| Q3 24 | $382.4M | $2.8B | ||
| Q2 24 | $411.4M | $2.9B | ||
| Q1 24 | $394.7M | $2.8B |
负债/权益比CVGWRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 1.0% | 8.9% |
| 资本支出强度资本支出/营收 | 0.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.60× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $19.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CVGWRGEN
| Q4 25 | $2.3M | $25.7M | ||
| Q3 25 | $8.0M | $48.1M | ||
| Q2 25 | $15.7M | $28.6M | ||
| Q1 25 | $-4.4M | $15.0M | ||
| Q4 24 | $10.8M | $39.2M | ||
| Q3 24 | $11.4M | $49.3M | ||
| Q2 24 | $2.1M | $42.2M | ||
| Q1 24 | $58.0K | $44.7M |
自由现金流CVGWRGEN
| Q4 25 | $1.2M | $17.6M | ||
| Q3 25 | $7.3M | $43.4M | ||
| Q2 25 | $15.6M | $21.5M | ||
| Q1 25 | $-4.7M | $11.4M | ||
| Q4 24 | $10.5M | $33.6M | ||
| Q3 24 | $11.3M | $42.3M | ||
| Q2 24 | $745.0K | $37.4M | ||
| Q1 24 | $-972.0K | $36.4M |
自由现金流率CVGWRGEN
| Q4 25 | 1.0% | 8.9% | ||
| Q3 25 | 4.1% | 23.0% | ||
| Q2 25 | 8.2% | 11.8% | ||
| Q1 25 | -3.1% | 6.8% | ||
| Q4 24 | 6.2% | 19.3% | ||
| Q3 24 | 6.3% | 27.3% | ||
| Q2 24 | 0.4% | 24.3% | ||
| Q1 24 | -0.8% | 24.0% |
资本支出强度CVGWRGEN
| Q4 25 | 0.9% | 4.1% | ||
| Q3 25 | 0.4% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.2% | 2.1% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.7% | 3.1% | ||
| Q1 24 | 0.8% | 5.5% |
现金转化率CVGWRGEN
| Q4 25 | 0.60× | 1.93× | ||
| Q3 25 | 1.69× | 3.23× | ||
| Q2 25 | 2.29× | 1.92× | ||
| Q1 25 | -1.00× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.35× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVGW
| Fresh Products | $104.7M | 84% |
| Segment Prepared | $14.5M | 12% |
| Tomatoes | $4.6M | 4% |
RGEN
暂无分部数据
